Top 10 Life Science VC (Venture Capital) Funds in Hong Kong in May 2025

Last updated: May 2025 A list of 10 VC (Venture Capital) funds that invest in Life science startups based in Hong kong. We rank investors based on the number of investments they made in Life science companies from Hong kong. We update this investor list every month.

Top 10 Life Science VC (Venture Capital) Funds in Hong Kong in May 2025

Investor	Life Science Hong Kong investments
Alibaba Entrepreneurs Fund	2
Alon Capital Ltd	1
Tiger Jade Capital	1
Vectr	1
AEF Greater Bay Area Fund	1
Hillhouse Ventures	1
Proxima Ventures Ltd	1
Gobi Partners	1
Hillhouse Investment	1
Prox Ventures	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.

Investment focus

Software, E-Commerce, Artificial Intelligence
Series A, Seed, Series B
Hong Kong, Taiwan, United States

Portfolio highlights

Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Rice Robotics Limited — The friendliest robot at your service.

Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies

Investment focus

Biopharma, Life Science, Biotechnology
Series A
Hong Kong

Portfolio highlights

Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.

Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc.

Investment focus

Biopharma, Life Science, Biotechnology
Series A
Hong Kong

Portfolio highlights

Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

Investment focus

FinTech, Financial Services, Artificial Intelligence
Seed, Series A, Pre-Seed
United States, Hong Kong, Singapore

Portfolio highlights

Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.

AEF Greater Bay Area Fund is an investment fund.

Investment focus

Biotechnology, Sports, Sustainability
Seed, Series A, Series B
Hong Kong, China, Macao

Portfolio highlights

ORCA-TECH — ORCA-TECH is a manufacturer of self-driving boat.
SleekFlow — SleekFlow makes customer messaging apps such as WhatsApp and Facebook connected to one platform for teams to better support and engage customers.
Scolioscan — Scolioscan focuses on medical imaging technology research & development, self-service production and technology distribution and promotion.

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Investment focus

Manufacturing, Biotechnology, Health Care
Series A, Series B, Seed
China, Singapore, Norway

Portfolio highlights

TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
Xinyanyi Code — Xinyanyi Code is an artificial intelligence programming application service provider that focuses on AI Coding and benchmarks the American intelligent code generation product Cursor.
Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.

Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services. Proxima Ventures was acquired by Soluto in October 2013. Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
China, United States, Israel

Portfolio highlights

VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
Immune-Onc Therapeutics — Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.

Gobi Partners: Leading Venture Capital in Asia. Accelerating Innovation, Fueling Success.

Investment focus

Financial Services, E-Commerce, Internet
Series A, Seed, Series B
China, Malaysia, Singapore

Portfolio highlights

RushOwl — RushOwl is a dynamic ride-sharing company that offers timely and affordable shuttle rides.
ChaZence — ChaZence is an environmental consulting and biotechnology company that manufactures, innovates, and designs naturally degradable materials for a sustainable lifestyle.
SkyeChip — Your Preferred cutting edge IP & IC Design solutions for artificial intelligence and high-performance computing.

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

dinii — Dinii is a mobile order platform for take-out shops.
Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.